文献速递贫血与红细胞疾病

英国育龄女性报告的贫血和月经过多患病率高于澳大利亚女性

Greater prevalence of anaemia and heavy menstrual bleeding reported in women of reproductive age in the United Kingdom compared to Australia.
PubMed 文献 · Br J Haematol · 2025-04-09

该横断面研究通过2016至2024年在英国和澳大利亚的筛查活动招募15-50岁女性,用自报问卷筛查月经过多(HMB)并测指尖血红蛋白(Hb<120 g/L判为贫血)。共纳入1937人(英国333人,澳大利亚1604人)。英国女性贫血风险更高(AOR 2.144,95%CI 1.545-2.946),HMB更常见(45.9% vs 31.2%),且贫血者中HMB比例更高(59.4% vs 30.3%)。

要点

  • 英国女性贫血风险高于澳大利亚女性(AOR 2.144,95%CI 1.545-2.946)。
  • 英国HMB患病率45.9%,高于澳大利亚的31.2%。
  • 澳大利亚贫血女性中30.3%有HMB,低于英国的59.4%。

核心结论

  • 英国育龄女性比澳大利亚女性更易患贫血和HMB,且HMB在英国带来更大的贫血风险。

研究设计与样本

  • 横断面研究,2016至2024年在英国和澳大利亚通过筛查活动招募15-50岁女性,共1937人(英国333人,澳大利亚1604人)。

主要发现

  • 英国平均Hb为129.2 ± 12.0 g/L,贫血占19.2%,其中59.4%有HMB。
  • 澳大利亚平均Hb为134.4 ± 12.2 g/L,高于英国(p < 0.001);贫血占9.7%,低于英国(p < 0.001);贫血者中HMB占30.3%,低于英国(p < 0.001)。
  • 英国女性贫血风险更高(AOR 2.144;95%CI 1.545, 2.946;p < 0.001)。
  • 英国HMB更常见(45.9% vs 31.2%;p < 0.001)。
  • 澳大利亚24.7%(299/1211)报告接受过静脉铁剂治疗;有既往静脉铁剂治疗者贫血可能性更低(AOR 0.616;95%CI 0.372, 0.982;p = 0.0496)。

关键数值与推荐

  • 贫血判定标准为指尖血红蛋白浓度Hb < 120 g/L。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Heavy periods are a common cause of anaemia in women of reproductive age. We compare the prevalence of anaemia and heavy menstrual bleeding (HMB) among women in the United Kingdom and Australia. Women aged 15-50 years were recruited through screening events conducted in the United Kingdom and Australia from 2016 to 2024. In these cross-sectional studies, self-report questionnaires screened for HMB and finger prick haemoglobin concentration (Hb) identified anaemia (Hb < 120 g/L). Of 1937 women (United Kingdom = 333, Australia = 1604), the mean age was 28.5 ± 9.2 years and 33.7% reported HMB. In the United Kingdom, the mean Hb was 129.2 ± 12.0 g/L and 19.2% were anaemic, of which 59.4% had HMB. In Australia, the mean Hb was higher (134.4 ± 12.2 g/L; p < 0.001), with fewer women being anaemic (9.7%; p < 0.001), and fewer anaemic women had HMB (30.3%; p < 0.001). Logistic regression analysis found that women in the United Kingdom were at a greater risk of being anaemic (AOR: 2.144; 95%CI:1.545, 2.946; p < 0.001). HMB was more common in the United Kingdom (45.9% vs. 31.2%; p < 0.001). In Australia, 24.7% (299/1211) reported receiving intravenous iron; while those with prior intravenous iron treatment were less likely to be anaemic (AOR: 0.616; 95%CI: 0.372, 0.982; p = 0.0496). Women in the United Kingdom are more likely to have anaemia and HMB than women in Australia, with HMB presenting a greater risk for anaemia development in the United Kingdom.

来源:Br J Haematol,查看原文。版权归原作者所有。

引用

  1. MacLean B, Fuller J, Lim J, et al. Greater prevalence of anaemia and heavy menstrual bleeding reported in women of reproductive age in the United Kingdom compared to Australia. Br J Haematol. 2025. PMID: 40200857. doi:10.1111/bjh.20075

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。